Growth Metrics

Pfizer (PFE) Property, Plant & Equipment (Net) (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 0.44%
Dec 31, 2025 2.31%
Sep 28, 2025 0.55%
Jun 29, 2025 2.34%
Mar 30, 2025 -0.25%
Dec 31, 2024 -0.80%
Sep 29, 2024 -2.19%
Jun 30, 2024 0.82%
Mar 31, 2024 -0.72%
Dec 31, 2023 6.04%
Oct 1, 2023 2.14%
Jul 2, 2023 2.56%
Apr 2, 2023 4.78%
Dec 31, 2022 5.39%
Oct 2, 2022 1.29%
Jul 3, 2022 0.89%
Apr 3, 2022 1.53%
Dec 31, 2021 3.09%
Oct 3, 2021 1.49%
Jul 4, 2021 1.52%
Apr 4, 2021 1.94%
Dec 31, 2020 -4.57%
Sep 27, 2020 2.05%
Jun 28, 2020 0.52%
Mar 29, 2020 8.26%
Dec 31, 2019 -5.34%
Sep 29, 2019 1.33%
Jun 30, 2019 0.40%
Mar 31, 2019 0.61%
Dec 31, 2018 -4.64%
Sep 30, 2018 0.84%
Jul 1, 2018 -0.37%
Apr 1, 2018 0.76%
Dec 31, 2017 2.67%
Oct 1, 2017 0.89%
Jul 2, 2017 1.12%
Apr 2, 2017 -0.60%
Dec 31, 2016 0.26%
Oct 2, 2016 -2.39%
Jul 3, 2016 0.18%
Apr 3, 2016 -1.32%
Dec 31, 2015 0.52%
Sep 27, 2015 19.80%
Jun 28, 2015 -0.82%
Mar 29, 2015 -2.00%
Dec 31, 2014 -2.24%
Sep 28, 2014 -1.21%
Jun 29, 2014 -1.36%
Mar 30, 2014 -0.40%
Dec 31, 2013 0.31%
Sep 29, 2013 -0.68%
Jun 30, 2013 -10.80%
Mar 31, 2013 5.58%
Dec 31, 2012 -9.54%
Sep 30, 2012 -1.02%
Jul 1, 2012 -8.87%
Apr 1, 2012 10.35%
Dec 31, 2011 -17.20%
Oct 2, 2011 -3.06%
Jul 3, 2011 -2.93%
Apr 3, 2011 6.96%
Dec 31, 2010 -9.48%
Oct 3, 2010 -2.95%
Jul 4, 2010 -7.44%
Apr 4, 2010 -4.96%
Dec 31, 2009 72.93%
Sep 27, 2009 -0.16%